Oak Associates’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,884
Closed -$467K 146
2026
Q1
$467K Sell
7,884
-5,798
-42% -$376K 0.03% 117
2025
Q4
$844K Sell
13,682
-700
-5% -$42.8K 0.05% 99
2025
Q3
$897K Sell
14,382
-195
-1% -$13.6K 0.05% 100
2025
Q2
$1.16M Buy
14,577
+137
+0.9% +$11.5K 0.08% 91
2025
Q1
$1.24M Sell
14,440
-115
-0.8% -$9.43K 0.09% 92
2024
Q4
$1.14M Hold
14,555
0.08% 100
2024
Q3
$1.05M Hold
14,555
0.07% 99
2024
Q2
$1M Buy
14,555
+248
+2% +$16.8K 0.07% 100
2024
Q1
$1.04M Hold
14,307
0.07% 103
2023
Q4
$876K Hold
14,307
0.07% 104
2023
Q3
$818K Hold
14,307
0.07% 104
2023
Q2
$850K Buy
14,307
+184
+1% +$11K 0.07% 105
2023
Q1
$885K Hold
14,123
0.07% 110
2022
Q4
$884K Buy
14,123
+5,123
+57% +$294K 0.07% 112
2022
Q3
$448K Buy
+9,000
New +$498K 0.04% 116

Other funds holding PBH

Oak Associates's PBH Position: Q2 2026 in Review

Oak Associates sold out of Prestige Consumer Healthcare (PBH) in Q2 2026, closing a stake of 7,884 shares — an estimated $467K sold.

Oak Associates first reported a position in PBH in Q3 2022 and held it in 15 quarters. The position peaked at $1.24M in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Oak Associates reported no remaining Prestige Consumer Healthcare position as of Q2 2026 after selling out during the quarter.
  • Oak Associates sold 7,884 Prestige Consumer Healthcare shares in Q2 2026, an estimated $467K.
  • Oak Associates first reported a position in Prestige Consumer Healthcare in Q3 2022 and held it in 15 quarters.
  • Oak Associates's Prestige Consumer Healthcare position peaked at $1.24M in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Oak Associates's 13F filing for Q2 2026, filed 14 Aug 2026.